HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia-Horng Kao Selected Research

Hepatitis B e Antigens

1/2022Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase.
1/2022Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study.
12/2021Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
6/2021Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
6/2021Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters.
1/2021Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
1/2020Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
1/2020HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
7/2018Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.
1/2018Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia-Horng Kao Research Topics

Disease

150Infections
08/2022 - 01/2002
104Chronic Hepatitis B
03/2022 - 01/2002
91Fibrosis (Cirrhosis)
03/2022 - 09/2002
77Chronic Hepatitis C
01/2022 - 10/2002
63Hepatitis B
05/2022 - 01/2002
62Hepatocellular Carcinoma (Hepatoma)
08/2022 - 09/2002
33Liver Diseases (Liver Disease)
01/2022 - 09/2002
31Hepatitis
06/2021 - 01/2003
24Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 07/2005
20Disease Progression
01/2022 - 09/2006
20Hepatitis C
06/2020 - 11/2002
19Neoplasms (Cancer)
08/2022 - 04/2002
18Virus Diseases (Viral Diseases)
02/2022 - 01/2007
14Chronic Hepatitis (Chronic Active Hepatitis)
11/2012 - 09/2002
9Insulin Resistance
10/2014 - 08/2005
8Coinfection
05/2022 - 01/2002
7Fatty Liver
04/2021 - 01/2005
6Viremia
12/2020 - 01/2003
5Non-alcoholic Fatty Liver Disease
03/2021 - 08/2009
5Inflammation (Inflammations)
06/2014 - 01/2005
4Chronic Renal Insufficiency
01/2022 - 06/2011
4Persistent Infection
07/2010 - 01/2003
3Carcinogenesis
01/2022 - 12/2018
3Hyperbilirubinemia
03/2018 - 04/2007
3Obesity
01/2018 - 05/2010
3Body Weight (Weight, Body)
10/2015 - 11/2012
3Cardiovascular Diseases (Cardiovascular Disease)
01/2010 - 08/2009
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010 - 01/2005
2Liver Neoplasms (Liver Cancer)
08/2022 - 01/2022
2Diabetes Mellitus
01/2022 - 05/2010
2Chronic Kidney Failure (Chronic Renal Failure)
08/2021 - 02/2011
2Hemorrhage
07/2020 - 12/2016
2HIV Infections (HIV Infection)
07/2020 - 04/2007
2Metabolic Diseases (Metabolic Disease)
01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

84Antiviral Agents (Antivirals)IBA
05/2022 - 01/2003
74InterferonsIBA
10/2021 - 11/2002
72Hepatitis B e AntigensIBA
01/2022 - 01/2002
60Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2021 - 10/2002
57DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2002
48Ribavirin (Virazole)FDA LinkGeneric
01/2022 - 11/2002
34Alanine Transaminase (SGPT)IBA
08/2021 - 01/2003
22Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2006
17SofosbuvirIBA
02/2022 - 01/2016
17entecavirFDA Link
01/2022 - 01/2006
16Lamivudine (Epivir)FDA Link
02/2015 - 02/2002
13RNA (Ribonucleic Acid)IBA
01/2022 - 06/2003
12peginterferon alfa-2a (Pegasys)FDA Link
01/2019 - 01/2006
11AntigensIBA
01/2022 - 01/2002
11Pharmaceutical PreparationsIBA
04/2021 - 08/2008
11daclatasvirIBA
01/2021 - 11/2014
10Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2020 - 11/2006
8alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2022 - 06/2003
8asunaprevirIBA
01/2021 - 11/2014
8Interferon-alpha (Interferon Alfa)IBA
07/2016 - 12/2002
7AdiponectinIBA
04/2015 - 08/2005
6sofosbuvir drug combination ledipasvirIBA
08/2022 - 07/2016
6glecaprevir and pibrentasvirIBA
01/2021 - 10/2018
5CytokinesIBA
05/2022 - 12/2011
5velpatasvirIBA
02/2022 - 12/2018
5Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2011
5nasIBA
01/2022 - 01/2014
5NucleotidesIBA
06/2021 - 10/2002
5CholesterolIBA
09/2020 - 07/2007
5VaccinesIBA
01/2020 - 09/2011
5LipidsIBA
01/2020 - 06/2008
5ledipasvirIBA
12/2018 - 06/2016
5Surface Antigens (Surface Antigen)IBA
03/2018 - 06/2012
5Transaminases (Aminotransferases)IBA
08/2017 - 11/2006
5Codon (Codons)IBA
07/2014 - 01/2002
4Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 07/2016
4Triglycerides (Triacylglycerol)IBA
01/2020 - 06/2008
4Ritonavir (Norvir)FDA Link
12/2018 - 10/2016
4TelbivudineFDA Link
01/2017 - 01/2014
4peginterferon alfa-2b (Pegintron)FDA Link
10/2014 - 01/2006
3Tenofovir (Viread)FDA Link
01/2022 - 01/2010
3BilirubinIBA
01/2022 - 03/2018
3Sorafenib (BAY 43-9006)FDA Link
11/2017 - 06/2015
3Viral DNAIBA
08/2017 - 11/2006
3Genetic Markers (Genetic Marker)IBA
06/2017 - 05/2015
3NucleosidesIBA
06/2016 - 01/2013
3AdipokinesIBA
04/2015 - 02/2008
3adefovir dipivoxil (Hepsera)FDA Link
02/2015 - 01/2006
3Complement System Proteins (Complement)IBA
09/2014 - 01/2013
3Amino AcidsFDA Link
01/2011 - 09/2002
2acarboxyprothrombin (PIVKA)IBA
08/2022 - 03/2022
2ChemokinesIBA
05/2022 - 08/2014
2Iodized OilIBA
02/2022 - 10/2021
2AlbuminsIBA
10/2021 - 12/2020
2Circular DNAIBA
06/2020 - 08/2014
2TransferasesIBA
01/2020 - 09/2009

Therapy/Procedure

134Therapeutics
05/2022 - 04/2002
11Liver Transplantation
03/2021 - 01/2008
9Renal Dialysis (Hemodialysis)
03/2019 - 01/2005
6Aftercare (After-Treatment)
01/2022 - 07/2005
6Duration of Therapy
06/2020 - 05/2005
5Drug Therapy (Chemotherapy)
01/2020 - 01/2008
4Highly Active Antiretroviral Therapy (HAART)
02/2012 - 02/2007
3Kidney Transplantation
05/2011 - 07/2010
2Radiofrequency Ablation
02/2022 - 10/2021
2Organ Transplantation
07/2020 - 01/2019